Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial

Fig. 3

Effect of Canagliflozin on renal fat fraction (FF) in newly diagnosed T2DM patients. A Kidney Dixion MRI images of two groups of newly diagnosed patients before and after treatment B Changes of renal FF in two groups before and after intervention C Analysis of correlation between baseline BMI and renal FF. * P < 0.05,** P < 0.01

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us